Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Diabetes. 2002 Mar;51(3):797–802. doi: 10.2337/diabetes.51.3.797

TABLE 3.

Rates of glucose and lipid oxidation before and after rosiglitazone therapy (mg/m2-min).

Pre-rosiglitazone Post-rosiglitazone p
Glucose oxidation
     Basal 32.4 ± 2.3 38.0 ± 5.0 0.24
     Low-dose clamp 38.0 ± 2.9 46.6 ± 3.2 0.11
     High-dose clamp 71.6 ± 4.7 73.5 ± 3.6 0.68
Lipid Oxidation
     Basal 158.5 ± 8.8 149.7 ± 17.3 0.24
     Low-dose clamp 138.9 ± 12.4 122.1 ± 8.9 0.33
     High-dose clamp   67.7 ± 13.7   71.1 ± 13.1 0.59